Patent · US Active

Process for producing and purifying factor VIII and its derivatives

US9441030B2 · kind B2 · utility

5Cited by
9References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2007
Grant dateSep 13, 2016
Priority date
Expiry dateFeb 23, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K1/22
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Disclosed is a method for producing proteins having factor VIII procoagulant activity in serum-free medium by in vitro culturing of mammalian cells, wherein the serum-free medium contains an inhibitor against the protease released from cultured cells. In accordance with this invention, the inhibitor can protect the cleavage of a target protein during cultivation and increase homogeneity of a target molecule, wherein the inhibitor can be a dextran sulfate. This invention also relates to a method of purifying target molecules from the culture medium containing both a target molecule and selected inhibitors by affinity chromatography.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.